ArticleClinical and translational radiation oncology2024

Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06).

Sebastian H Maier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.